Curcumin and Tulsi For Pulmonary Disorders In Pandemic Century

Abstract

Asthma, a chronic respiratory disorder, is witnessing an increasing global incidence, necessitating exploration of alternative treatments beyond conventional therapies. This study reviews the therapeutic potential of natural products, namely curcumin and tulsi, in managing asthma, juxtaposed against the backdrop of conventional pharmaceuticals. Adverse effects and limitations of current medications such as short-acting agonists, inhaled corticosteroids, and monoclonal antibodies are highlighted. Moreover, embryonic risks associated with these drugs further underscore the need for safer alternatives. Experimental findings suggest the efficacy of curcumin in reducing airway obstruction and inflammation, backed by its safety profile. Tulsi (holy basil), a mainstay in Ayurvedic treatment, also demonstrates promising effects in alleviating asthma symptoms. Future research will expand on this foundation to provide a holistic, natural treatment approach to asthma management.